Publications by authors named "Felipe Samaniego"

100Publications

Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients.

Hematol Oncol 2020 Aug 1;38(3):301-308. Epub 2020 Apr 1.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
August 2020

Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection.

Blood 2019 06 17;133(26):2800-2802. Epub 2019 May 17.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
June 2019

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.

Clin Lymphoma Myeloma Leuk 2019 06 26;19(6):381-389. Epub 2019 Feb 26.

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
June 2019

Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.

Am J Gastroenterol 2019 02;114(2):250-257

Departments of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
February 2019

Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.

Ophthalmic Plast Reconstr Surg 2019 May/Jun;35(3):243-246

Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.

View Article and Find Full Text PDF
January 2020

Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.

Int J Cancer 2018 03 3;142(5):940-948. Epub 2017 Nov 3.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
March 2018

The oncologic burden of hepatitis C virus infection: A clinical perspective.

CA Cancer J Clin 2017 Sep 6;67(5):411-431. Epub 2017 Jul 6.

Professor of Hepatology, Public Assistance - Paris Hospitals (AP-HP), Hepatology Service, Cochin Port-Royal Hospital, Paris Descartes University (Paris V), National Institute of Health and Medical Research (INSERM), Unit 1223, Pasteur Institute, Paris, France.

View Article and Find Full Text PDF
September 2017

LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.

J Transl Med 2016 12 20;14(1):346. Epub 2016 Dec 20.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article and Find Full Text PDF
December 2016

Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.

Haematologica 2017 02 14;102(2):373-380. Epub 2016 Oct 14.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

View Article and Find Full Text PDF
February 2017

Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.

Ophthalmic Plast Reconstr Surg 2017 Sep/Oct;33(5):355-360

*Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, †Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, ‡Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, U.S.A.; §Narayana Nethralaya, Narayana Health City, Bangalore, India; ‖Department of Lymphoma and Myeloma, ¶Department of Radiation Oncology, and #Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.

View Article and Find Full Text PDF
September 2017

Resolution of lung adenocarcinoma after discontinuation of ibrutinib.

BMJ Case Rep 2016 Jul 18;2016. Epub 2016 Jul 18.

Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
July 2016

Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy.

Leuk Lymphoma 2017 02 27;58(2):485-488. Epub 2016 Jun 27.

a Department of Infectious Diseases, Infection Control, and Employee Health , The University of Texas M.D. Anderson Cancer Center , Houston , TX , USA.

View Article and Find Full Text PDF
February 2017

Small Lymphocytic Lymphoma Presenting with Hypopituitarism.

Am J Med 2016 Jan 5;129(1):e9-e10. Epub 2015 Sep 5.

Cancer Center of Kansas, Wichita.

View Article and Find Full Text PDF
January 2016

Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma.

Haematologica 2015 Nov 6;100(11):e454-7. Epub 2015 Aug 6.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Houston, TX, USA.

View Article and Find Full Text PDF
November 2015

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.

Br J Haematol 2015 Nov 27;171(4):463-70. Epub 2015 Jul 27.

Department of Lymphoma/Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
November 2015

Spontaneous regression of interdigitating dendritic sarcoma in a patient with concurrent small lymphocytic lymphoma.

BMJ Case Rep 2015 Jun 12;2015. Epub 2015 Jun 12.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
June 2015

Targeting Wnt pathway in mantle cell lymphoma-initiating cells.

J Hematol Oncol 2015 Jun 6;8:63. Epub 2015 Jun 6.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article and Find Full Text PDF
June 2015

Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.

J Invest Dermatol 2015 Nov 3;135(11):2775-2784. Epub 2015 Jun 3.

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article and Find Full Text PDF
November 2015

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.

Haematologica 2015 Jul 27;100(7):e272-4. Epub 2015 Mar 27.

Department of Lymphoma and Myeloma, University of Texas, MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article and Find Full Text PDF
July 2015

Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.

PLoS One 2015 4;10(3):e0117994. Epub 2015 Mar 4.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article and Find Full Text PDF
November 2015

HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.

Mol Cancer Res 2015 May 12;13(5):809-18. Epub 2015 Feb 12.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
May 2015

CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.

J Exp Clin Cancer Res 2014 Oct 10;33:80. Epub 2014 Oct 10.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article and Find Full Text PDF
October 2014

Lymphoid hyperplasia and lymphoma in KSHV K1 transgenic mice.

Histol Histopathol 2015 May 10;30(5):559-68. Epub 2014 Oct 10.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
May 2015

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.

Blood 2013 Jun 18;121(23):4729-39. Epub 2013 Apr 18.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

View Article and Find Full Text PDF
June 2013

The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.

J Exp Clin Cancer Res 2012 Aug 28;31:69. Epub 2012 Aug 28.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article and Find Full Text PDF
August 2012

Second-line 90Yttrium-ibritumomab tiuxetan (Zevalin) in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma refractory to rituximab.

Ophthalmic Plast Reconstr Surg 2012 Nov-Dec;28(6):e145-6

Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
March 2013

The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal.

Blood 2011 Nov 19;118(20):5429-38. Epub 2011 Sep 19.

Department of Molecular and Cellular Oncology, M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA.

View Article and Find Full Text PDF
November 2011

PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo.

Blood 2011 Sep 29;118(11):3107-18. Epub 2011 Jul 29.

Departments of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
September 2011

Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737.

Cancer 2012 Feb 14;118(4):1023-31. Epub 2011 Jul 14.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
February 2012

Treatment of benign lymphoid hyperplasia of the orbit with rituximab.

Ophthalmic Plast Reconstr Surg 2010 Jan-Feb;26(1):11-3

Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
April 2010

Milatuzumab - a promising new immunotherapeutic agent.

Expert Opin Investig Drugs 2010 Jan;19(1):141-9

The University of Texas, MD Anderson Cancer Center, Department of Lymphoma/Myeloma, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
January 2010

Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

J Natl Cancer Inst 2009 Mar 10;101(6):399-411. Epub 2009 Mar 10.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, 77054, USA.

View Article and Find Full Text PDF
March 2009

Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

Blood 2007 Jun 22;109(12):5455-62. Epub 2007 Feb 22.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
June 2007

K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis.

Blood 2007 Mar 7;109(5):2174-82. Epub 2006 Nov 7.

Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
March 2007